ScoreWhy is Tarsons Products Ltd ?
1
Poor long term growth as Operating profit has grown by an annual rate -18.84% of over the last 5 years
2
Negative results in Sep 25
- PAT(Latest six months) At Rs 5.10 cr has Grown at -64.36%
- ROCE(HY) Lowest at 6.69%
- DEBT-EQUITY RATIO(HY) Highest at 0.41 times
3
With ROCE of 3.9, it has a Expensive valuation with a 1.6 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -49.63%, its profits have fallen by -30%
4
Falling Participation by Institutional Investors
- Institutional investors have decreased their stake by -3.27% over the previous quarter and collectively hold 5.91% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
5
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -49.63% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Healthcare Services)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Tarsons Products for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Tarsons Products
-49.94%
-1.09
45.58%
Sensex
4.89%
0.40
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
32.40%
EBIT Growth (5y)
-18.84%
EBIT to Interest (avg)
12.03
Debt to EBITDA (avg)
3.13
Net Debt to Equity (avg)
0.58
Sales to Capital Employed (avg)
0.36
Tax Ratio
36.23%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
5.91%
ROCE (avg)
5.88%
ROE (avg)
9.82%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
59
Industry P/E
38
Price to Book Value
1.94
EV to EBIT
40.60
EV to EBITDA
13.31
EV to Capital Employed
1.59
EV to Sales
3.93
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
3.93%
ROE (Latest)
3.28%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend0What is working for the Company
NO KEY POSITIVE TRIGGERS
-13What is not working for the Company
PAT(Latest six months)
At Rs 5.10 cr has Grown at -64.36%
ROCE(HY)
Lowest at 6.69%
DEBT-EQUITY RATIO(HY)
Highest at 0.41 times
NON-OPERATING INCOME(Q)
is 103.76 % of Profit Before Tax (PBT
Loading Valuation Snapshot...
Here's what is not working for Tarsons Products
Profit After Tax (PAT) - Quarterly
At Rs 3.32 cr has Fallen at -51.8% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 6.88 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Non Operating Income - Quarterly
is 103.76 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model
Non Operating Income to PBT
Debt-Equity Ratio - Half Yearly
Highest at 0.41 times
in the last five half yearly periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
